Genetic Analysis Market (By Product: Reagents & Kits, Instruments, Software; By Test: Predictive Genetic Testing, Carrier Testing, Prenatal and Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Others; By Technology: Next-Generation Sequencing, Real-Time PCR System, Others; By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genetic Analysis Market 

5.1. COVID-19 Landscape: Genetic Analysis Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genetic Analysis Market, By Product

8.1. Genetic Analysis Market, by Product, 2024-2033

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Software

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Genetic Analysis Market, By Test

9.1. Genetic Analysis Market, by Test, 2024-2033

9.1.1. Predictive Genetic Testing

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Carrier Testing

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Prenatal and Newborn Testing

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Disease Diagnostic Testing

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Pharmacogenomic Testing

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Genetic Analysis Market, By Technology 

10.1. Genetic Analysis Market, by Technology, 2024-2033

10.1.1. Next-Generation Sequencing (NGS)

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Real-Time PCR System

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Genetic Analysis Market, By Application

11.1. Genetic Analysis Market, by Application, 2024-2033

11.1.1. Cancer

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Genetic Diseases

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Cardiovascular Diseases

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Rare Diseases

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Infectious Diseases

11.1.5.1. Market Revenue and Forecast (2021-2033)

11.1.6. Others

11.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Genetic Analysis Market, By End-use

12.1. Genetic Analysis Market, by End-use, 2024-2033

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Research & Development Laboratories

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Diagnostic Centers

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Genetic Analysis Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Forecast, by Test (2021-2033)

13.1.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.5. Market Revenue and Forecast, by End-use (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Test (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Forecast, by Test (2021-2033)

13.1.7.3. Market Revenue and Forecast, by Technology (2021-2033)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Forecast, by Test (2021-2033)

13.2.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.4. Market Revenue and Forecast, by Application (2021-2033) 

13.2.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Test (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.7. Market Revenue and Forecast, by Application (2021-2033) 

13.2.8. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Test (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.10. Market Revenue and Forecast, by Application (2021-2033)

13.2.11. Market Revenue and Forecast, by End-use (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Test (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.13. Market Revenue and Forecast, by End-use (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Test (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Technology (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.15. Market Revenue and Forecast, by End-use (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Forecast, by Test (2021-2033)

13.3.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Test (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.7. Market Revenue and Forecast, by End-use (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Test (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.9. Market Revenue and Forecast, by End-use (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Test (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Test (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Technology (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Forecast, by Test (2021-2033)

13.4.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Test (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.7. Market Revenue and Forecast, by End-use (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Test (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.9. Market Revenue and Forecast, by End-use (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Test (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Test (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Technology (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Forecast, by Test (2021-2033)

13.5.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Test (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.7. Market Revenue and Forecast, by End-use (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Test (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Technology (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Abbott Laboratories

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. PerkinElmer, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. BioRad Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. AutoGenomics Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. ELITech Group

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. IntegraGen

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Quest Diagnostics Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Hoffmann-La Roche AG

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Celera Group

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample